Who
Scott Hirsch
Director
Company insider
Files Form 4 as: Director, Keenova Therapeutics.
In numbers
- Trades disclosed
- 13
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 14 Aug 2025
- Last trade
- 15 Jul 2026
- Last filed
- 17 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jul 2026filed 17 Jul 2026 | Keenova Therapeuticsoption or derivative | SEC FORM 4 Code A | —4,406 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Keenova Therapeuticsoption or derivative | SEC FORM 4 Code A | —4,406 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | Keenova Therapeutics | SEC FORM 4 Code M | —2,685 | filing |
| 2 Jun 2026filed 4 Jun 2026 | Keenova Therapeutics | SEC FORM 4 Code F | —619 | filing |
| 2 Jun 2026filed 4 Jun 2026 | Keenova Therapeuticsoption or derivative | SEC FORM 4 Code D | —2,197 | filing |
| 2 Jun 2026filed 4 Jun 2026 | Keenova Therapeuticsoption or derivative | SEC FORM 4 Code D | —2,197 | filing |
| 2 Jun 2026filed 4 Jun 2026 | Keenova Therapeuticsoption or derivative | SEC FORM 4 Code M | —2,685 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | Keenova Therapeuticsoption or derivative | SEC FORM 4 Code M | —2,685 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | Keenova Therapeutics | SEC FORM 4 Code M | —2,685 | filing |
| 2 Jun 2026filed 4 Jun 2026 | Keenova Therapeutics | SEC FORM 4 Code F | —619 | filing |
| 23 Feb 2026filed 25 Feb 2026 | Keenova Therapeuticsoption or derivative | SEC FORM 4 Code A | —3,984 at $0.00 | filing |
| 23 Feb 2026filed 25 Feb 2026 | Keenova Therapeuticsoption or derivative | SEC FORM 4 Code A | —3,984 at $0.00 | filing |
| 14 Aug 2025filed 18 Aug 2025 | Mallinckrodtoption or derivative | SEC FORM 4 Code A | —4,062 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.